The chemical compound “anle138b” eases cognitive deficits and normalizes gene expression in a mouse model of Alzheimer’s disease.
Joint Press Release by DZNE, MPI-BPC & UMG
Göttingen (Germany),…
Scientists at the DZNE in Magdeburg are developing an innovative therapy based on virtual reality to treat social anxiety disorders. For this purpose, the European Research Council is providing about…
Study led by the University of Bonn, which also involved researchers of the DZNE shows that even after a change to a healthy diet, the body‘s defenses remain hyperactive.
The body’s defenses remain…
DZNE, ChemDiv and Torrey Pines Investment Launch Inflammasome Discovery Program of Translational Collaboration on Neurodegeneration
DZNE, ChemDiv and Torrey Pines Investment Launch Inflammasome…
According to a study by scientists of the German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn now published in the journal “Nature”, inflammatory mechanisms caused by the…
Eicke Latz, director of the Institute of Innate Immunity at the University of Bonn and scientist at the DZNE will be awarded the “Gottfried Wilhelm Leibniz Prize”, which is considered as the most…
Welcome to our website, here you can inform yourself basically cookie-free.
We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.
